Alex Waterson
-
Vanderbilt-discovered cancer killing compound is now available through Boehringer Ingelheim open science portal opnMe
By targeting a notoriously undruggable protein found in many cancers, the discovery of BI-0474 may pave the way for new cancer treatments. Shared on opnMe.com by Boehringer Ingelheim, this innovative molecule is available for global researchers to explore new research avenues. Read MoreMay. 28, 2024
-
Kojetin, Waterson named Vanderbilt Innovation Ambassadors
Within the intellectual powerhouse that is Vanderbilt University and Vanderbilt University Medical Center thrives a group of doctors, engineers, computer scientists and others who also are visionaries, inventors and entrepreneurs. Several of these change-makers also donate their time and expertise through the Vanderbilt Innovation Ambassadors Program to help colleagues in their departments recognize and pursue the world-altering potential of their own ideas. Read MoreMay. 13, 2024
-
Sean Davies awarded Scaling Success grant to develop small molecules with promise of protecting against cardiometabolic disease
Davies received a Scaling Success grant to advance research on NAPE-PLD activators—potential key players in fighting cardiometabolic diseases. The team’s innovative research could lead to breakthrough treatments. Read MoreMar. 28, 2024
-
Celebrating recent appointments and promotions in Basic Sciences
We extend congratulations to our many community members who were recently promoted or received new appointments. These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read MoreJan. 24, 2024